185 related articles for article (PubMed ID: 18473993)
1. Receptor tyrosine kinases as therapeutic targets in malignant glioma.
Ren H; Yang BF; Rainov NG
Rev Recent Clin Trials; 2007 May; 2(2):87-101. PubMed ID: 18473993
[TBL] [Abstract][Full Text] [Related]
2. Targeted molecular therapy of malignant gliomas.
Kesari S; Ramakrishna N; Sauvageot C; Stiles CD; Wen PY
Curr Neurol Neurosci Rep; 2005 May; 5(3):186-97. PubMed ID: 15865884
[TBL] [Abstract][Full Text] [Related]
3. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
4. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
[TBL] [Abstract][Full Text] [Related]
5. Targeted molecular therapy of malignant gliomas.
Kesari S; Ramakrishna N; Sauvageot C; Stiles CD; Wen PY
Curr Oncol Rep; 2006 Jan; 8(1):58-70. PubMed ID: 16464405
[TBL] [Abstract][Full Text] [Related]
6. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
7. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
8. Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity.
Baro M; Lopez Sambrooks C; Quijano A; Saltzman WM; Contessa J
Clin Cancer Res; 2019 Jan; 25(2):784-795. PubMed ID: 29967251
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase inhibitors.
Haluska P; Adjei AA
Curr Opin Investig Drugs; 2001 Feb; 2(2):280-6. PubMed ID: 11816845
[TBL] [Abstract][Full Text] [Related]
10. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
Takeuchi H; Kondo Y; Fujiwara K; Kanzawa T; Aoki H; Mills GB; Kondo S
Cancer Res; 2005 Apr; 65(8):3336-46. PubMed ID: 15833867
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
12. Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management.
Paranthaman S; Goravinahalli Shivananjegowda M; Mahadev M; Moin A; Hagalavadi Nanjappa S; Nanjaiyah N; Chidambaram SB; Gowda DV
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33321953
[TBL] [Abstract][Full Text] [Related]
13. The challenges and the promise of molecular targeted therapy in malignant gliomas.
Wang H; Xu T; Jiang Y; Xu H; Yan Y; Fu D; Chen J
Neoplasia; 2015 Mar; 17(3):239-55. PubMed ID: 25810009
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies for malignant glioma: progress and potential.
Mercer RW; Tyler MA; Ulasov IV; Lesniak MS
BioDrugs; 2009; 23(1):25-35. PubMed ID: 19344189
[TBL] [Abstract][Full Text] [Related]
15. The role of RICTOR downstream of receptor tyrosine kinase in cancers.
Jebali A; Dumaz N
Mol Cancer; 2018 Feb; 17(1):39. PubMed ID: 29455662
[TBL] [Abstract][Full Text] [Related]
16. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2016 Feb; 109():314-41. PubMed ID: 26807863
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinases as targets in cancer therapy - successes and failures.
Traxler P
Expert Opin Ther Targets; 2003 Apr; 7(2):215-34. PubMed ID: 12667099
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Targeted Therapy for Glioma.
Lin L; Cai J; Jiang C
Curr Med Chem; 2017; 24(13):1365-1381. PubMed ID: 28019637
[TBL] [Abstract][Full Text] [Related]
20. Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy.
Abounader R
Expert Rev Anticancer Ther; 2009 Feb; 9(2):235-45. PubMed ID: 19192961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
